Latest News for: alzing

Edit

Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data

Hastings Tribune 25 Mar 2025
Simufilam did not show a significant reduction in co-primary ...
Edit

Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data (Form 8-K) (Cassava Sciences Inc)

Public Technologies 25 Mar 2025
REFOCUS-ALZ enrolled ... "We are disappointed that the results of REFOCUS-ALZ and RETHINK-ALZ showed no treatment benefit for patients with mild-to-moderate Alzheimer's disease ... About REFOCUS-ALZ.
  • 1
×